DNA Patent In Monsanto Suit Upheld On Re-Exam
The patent office upheld all the claims without amendment in a re-examination action over U.S. Patent Number 5,612,179, GTG said Monday in a regulatory filing with the U.S. Securities and Exchange Commission.
"This is the best possible result for the company," said GTG CEO Paul MacLeman. "We...
To view the full article, register now.